News

• Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
  01/11/2021 / 13:30 - GlobeNewswire
•  
• Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
  01/08/2021 / 13:30 - GlobeNewswire
•  
• The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
  12/21/2020 / 13:30 - GlobeNewswire
•  
• Biogen agrees to $22M settlement to resolve claims on illegal business
  12/17/2020 / 20:04 - TeleTrader
•  
• Biogen Files New Drug Application for Aducanumab in Japan
  12/10/2020 / 04:30 - GlobeNewswire
•  
• Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
  12/02/2020 / 14:30 - GlobeNewswire
•  
• Spero Therapeutics Announces Appointment of Tamara Joseph as Chief Legal Officer
  12/02/2020 / 14:30 - GlobeNewswire
•  
• Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
  11/27/2020 / 13:30 - GlobeNewswire
•  
• Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
  11/18/2020 / 13:00 - GlobeNewswire
•  
• Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership
  11/16/2020 / 13:30 - GlobeNewswire
•  
• Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
  11/07/2020 / 02:15 - GlobeNewswire
•  
• Biogen surges over 40% on Alzheimer's drug news
  11/04/2020 / 18:41 - TeleTrader
•  
• Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting
  11/03/2020 / 13:30 - GlobeNewswire
•  
• X4 Pharmaceuticals Appoints Art Taveras, Ph.D., as Chief Scientific Officer
  11/02/2020 / 14:00 - GlobeNewswire
•  
• European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
  10/30/2020 / 12:00 - GlobeNewswire